Sight Sciences to earn $34M from Alcon patent infringement suit
Sight Sciences announced today that it received a jury trial verdict awarding it $34 million from a patent infringement case against Alcon.
Source: massdevice.com
Stay updated with breaking news from Sight Sciences Nasdaq. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sight Sciences announced today that it received a jury trial verdict awarding it $34 million from a patent infringement case against Alcon.
Sight Sciences (Nasdaq:SGHT) announced that it closed a senior secured credit facility worth up to $65 million.
Innovation finds its way into all areas of medtech, and ophthalmic treatments represent another burgeoning space.